Skip to main content
. 2014 Mar 20;9(3):e91124. doi: 10.1371/journal.pone.0091124

Figure 2. Forest plot showing the associations of the time to progression (TTP) between TACE alone group and sorafenib combined with TACE group for patients with unresctable HCC.

Figure 2

The result of meta-analysis for TTP between TACE alone group and sorafenib combined with TACE group for patients with unresctable HCC. Studies are arranged by publication year. Forrest plot displayed as hazard ratio and 95% confidence intervals. (HR, hazard ratio; CI, confidence interval).